Copeptin predicts coronary artery disease cardiovascular and total mortality.

Irina Tasevska; Sofia Enhörning; Margaretha Persson; Peter Nilsson; Olle Melander

doi:10.1136/heartjnl-2015-308183

Copeptin predicts coronary artery disease cardiovascular and total mortality.

Irina Tasevska, Sofia Enhörning, Margaretha Persson, Peter Nilsson, Olle Melander

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Sammanfattning

In a middle-aged population, it was recently shown that the stable vasopressin marker plasma copeptin (copeptin) predicts development of diabetes mellitus, diabetic heart disease and death. Here, it was hypothesised whether copeptin predicts a risk of coronary artery disease (CAD), and cardiovascular mortality in an older population.

Originalspråk	engelska
Sidor (från-till)	127-132
Tidskrift	Heart
Volym	102
Nummer	2
DOI	https://doi.org/10.1136/heartjnl-2015-308183
Status	Published - 2016

Ämnesklassifikation (UKÄ)

Kardiologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1136/heartjnl-2015-308183

http://www.ncbi.nlm.nih.gov/pubmed/26661323?dopt=Abstract

1 Doktorsavhandling (sammanläggning)

Vasopressin, cardiorenal disease and hydration. The vasopressin system in relation to the risk of cardiorenal disease and how vasopressin levels are affected by salt and water interventions in humans.
Tasevska, I., 2017, Lund: Lund University: Faculty of Medicine. 76 s.
Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Öppen tillgång
Fil

Citera det här

@article{00bde55a1331435fae6ed18a2910f06d,

title = "Copeptin predicts coronary artery disease cardiovascular and total mortality.",

abstract = "In a middle-aged population, it was recently shown that the stable vasopressin marker plasma copeptin (copeptin) predicts development of diabetes mellitus, diabetic heart disease and death. Here, it was hypothesised whether copeptin predicts a risk of coronary artery disease (CAD), and cardiovascular mortality in an older population.",

author = "Irina Tasevska and Sofia Enh{\"o}rning and Margaretha Persson and Peter Nilsson and Olle Melander",

year = "2016",

doi = "10.1136/heartjnl-2015-308183",

language = "English",

volume = "102",

pages = "127--132",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Copeptin predicts coronary artery disease cardiovascular and total mortality.

AU - Tasevska, Irina

AU - Enhörning, Sofia

AU - Persson, Margaretha

AU - Nilsson, Peter

AU - Melander, Olle

PY - 2016

Y1 - 2016

N2 - In a middle-aged population, it was recently shown that the stable vasopressin marker plasma copeptin (copeptin) predicts development of diabetes mellitus, diabetic heart disease and death. Here, it was hypothesised whether copeptin predicts a risk of coronary artery disease (CAD), and cardiovascular mortality in an older population.

AB - In a middle-aged population, it was recently shown that the stable vasopressin marker plasma copeptin (copeptin) predicts development of diabetes mellitus, diabetic heart disease and death. Here, it was hypothesised whether copeptin predicts a risk of coronary artery disease (CAD), and cardiovascular mortality in an older population.

U2 - 10.1136/heartjnl-2015-308183

DO - 10.1136/heartjnl-2015-308183

M3 - Article

C2 - 26661323

SN - 1355-6037

VL - 102

SP - 127

EP - 132

JO - Heart

JF - Heart

IS - 2

ER -

Copeptin predicts coronary artery disease cardiovascular and total mortality.

Sammanfattning

Ämnesklassifikation (UKÄ)

FN:s Globala mål

Tillgång till dokument

Fingeravtryck

Forskningsoutput

Vasopressin, cardiorenal disease and hydration. The vasopressin system in relation to the risk of cardiorenal disease and how vasopressin levels are affected by salt and water interventions in humans.

Citera det här